title: Management of prenatally diagnosed lung lesions.
abstract: Prenatal diagnosis provides insight into the in utero evolution of fetal thoracic lesions such as congenital cystic adenomatoid malformation (CCAM), bronchopulmonary sequestration (BPS), or hybrid lesions. Serial sonographic study of fetuses with thoracic lesions has helped define the natural history of these lesions, determine the pathophysiologic features that affect clinical outcome, and formulate in utero and postnatal management based on prognosis.
authors: The Center for Fetal Diagnosis and Treatment, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA. khalekn@email.chop.edu
authors: Nahla
authors: N
authors: Khalek
authors: Mark P
authors: MP
authors: Johnson
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001623:Betamethasone / Q000627:therapeutic use; D001998:Bronchopulmonary Sequestration / Q000000981:diagnostic imaging / Q000196:embryology / Q000503:physiopathology / Q000628:therapy*; D015615:Cystic Adenomatoid Malformation of Lung, Congenital / Q000000981:diagnostic imaging / Q000196:embryology / Q000503:physiopathology / Q000628:therapy*; D005260:Female; D046128:Fetal Therapies / Q000379:methods*; D005333:Fetus / Q000196:embryology / Q000503:physiopathology / Q000601:surgery; D006801:Humans; D007231:Infant, Newborn; D018743:Perinatal Care; D011013:Pneumonectomy / Q000379:methods; D011181:Postnatal Care; D011247:Pregnancy; D016216:Ultrasonography, Prenatal
chemical_list: D000893:Anti-Inflammatory Agents; D001623:Betamethasone